Allspring Global Investments Holdings LLC increased its stake in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Rating) by 278.2% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 478,815 shares of the company’s stock after buying an additional 352,208 shares during the period. Allspring Global […]
Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Rating) Director Richard W. Mott sold 38,498 shares of Treace Medical Concepts stock in a transaction on Thursday, March 30th. The stock was sold at an average price of $26.00, for a total transaction of $1,000,948.00. Following the completion of the sale, the director now owns 1,020,000 shares […]
Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Rating) saw a significant growth in short interest in March. As of March 15th, there was short interest totalling 1,250,000 shares, a growth of 21.4% from the February 28th total of 1,030,000 shares. Based on an average daily trading volume, of 382,500 shares, the short-interest ratio is presently […]
Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Rating) Director F Barry Bays sold 26,241 shares of the stock in a transaction on Tuesday, March 28th. The stock was sold at an average price of $25.02, for a total value of $656,549.82. Following the completion of the transaction, the director now owns 1,237,242 shares of the […]
Treace Medical Concepts (NASDAQ:TMCI – Get Rating) and Nephros (NASDAQ:NEPH – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, profitability, valuation, earnings and risk. Insider & Institutional Ownership 46.2% of Treace Medical Concepts […]